St. Jude gene therapy improves immunity in babies with ‘bubble boy’ disease – EurekAlert (press release)
EurekAlert (press release) |
St. Jude gene therapy improves immunity in babies with ‘bubble boy’ disease
EurekAlert (press release) Early evidence suggests that gene therapy developed at St. Jude Children’s Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder. Preliminary results from the … |
|
Another Gene Therapy Breakthrough Against Hemophilia
U.S. News & World Report SATURDAY, Dec. 9, 2017 (HealthDay News) — Coming just days after reports of a gene therapy that pushed the bleeding disorder hemophilia B into remission, new research suggests the same could be true for adults with the “A” form of the disease. That’s … Hemophilia Gene Therapy Global Market Sees Promising Growth during 2017-2022: Novo Nordisk A/S, PfizerMilTech |
STAT |
BioMarin’s gene therapy reduces bleeding in hemophilia patients, making Roche look over its shoulder
STAT ATLANTA — Hemophilia researchers representing Roche (RHBBY 1) and BioMarin Pharmaceuticals (BMRN 2) shared a dais Saturday during a media briefing at the American Society of Hematology (ASH) annual meeting. That’s fitting because both companies are … |
The Oakland Press |
Gene therapy shows promise against blood-clotting disease
The Oakland Press Gene therapy shows promise against blood-clotting disease. This Saturday, Dec. 2, 2017 photo provided by Jay Konduros, left, shows him and his brother, Bill, at Jay’s home in Cambridge, Ontario, Canada. The brothers, who have hemophilia, were involved … |